Global perspectives of determinants influencing HPV vaccine introduction and scale-up in low- and middle-income countries
Global perspectives of determinants influencing HPV vaccine introduction and scale-up in low- and middle-income countries is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Global perspectives of determinants influencing HPV vaccine introduction and scale-up in low- and middle-income countries have?
Global perspectives of determinants influencing HPV vaccine introduction and scale-up in low- and middle-income countries has 63 citations in the OpenAlex counts ScholarIQ stores.
When was Global perspectives of determinants influencing HPV vaccine introduction and scale-up in low- and middle-income countries published?
Global perspectives of determinants influencing HPV vaccine introduction and scale-up in low- and middle-income countries has 2024 year in the ScholarIQ index.
What is the open-access status of Global perspectives of determinants influencing HPV vaccine introduction and scale-up in low- and middle-income countries?
Global perspectives of determinants influencing HPV vaccine introduction and scale-up in low- and middle-income countries has gold oa status in the ScholarIQ index.
What is the DOI of Global perspectives of determinants influencing HPV vaccine introduction and scale-up in low- and middle-income countries?
The DOI for Global perspectives of determinants influencing HPV vaccine introduction and scale-up in low- and middle-income countries is on the source record.
What is the PMID of Global perspectives of determinants influencing HPV vaccine introduction and scale-up in low- and middle-income countries?
The PMID for Global perspectives of determinants influencing HPV vaccine introduction and scale-up in low- and middle-income countries is on the source record.
What is the OpenAlex record for Global perspectives of determinants influencing HPV vaccine introduction and scale-up in low- and middle-income countries?
The OpenAlex for Global perspectives of determinants influencing HPV vaccine introduction and scale-up in low- and middle-income countries is on the source record.